Neurosurgery One reports that new-onset seizures can signal brain tumors, prompting urgent investigation, with up to 50% of ...

Late-onset epilepsy (LOE) may represent a distinctive neurodegenerative-linked epilepsy subtype, with new data showing that individuals who develop epilepsy after midlife have substantially greater ...

CMP-002 administration resulted in a statistically significant improvement in seizure phenotypes and parameters in a SYNGAP1 haploinsufficient mouse model Results build upon prior preclinical evidence ...

Researchers assessed whether semaglutide initiation was associated with risk for adult-onset epilepsy or seizures in adults ...

Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in ...

Xenon Pharmaceuticals released positive topline results from a phase three study of its azetukalner drug for focal onset seizures. The study met its primary endpoint for median percent change in ...

A dedicated pediatric First Seizure Clinic (FSC) provided specialist evaluation in less than a week and enabled an epilepsy diagnosis at the initial visit for more than 1 in 5 children. The findings ...

March 9 (Reuters) - Xenon Pharmaceuticals (XENE.O), opens new tab said on Monday its experimental epilepsy drug met the main goal of showing a statistically significant reduction ‌in focal onset ...

1 to 1.5 million children in India are living with epilepsy, which is a brain condition that is caused by unusual electrical activity. The symptoms of epilepsy include brief staring spells, confusion, ...

While uncommon, seizures affect about 5 percent of people with multiple sclerosis. Learn about the link between MS and seizures, how they are treated, and when to see a doctor.